Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects

Intern Med. 2002 Oct;41(10):793-7. doi: 10.2169/internalmedicine.41.793.


Objective: The acute effects of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism were evaluated.

Methods: Losartan (50 mg) was administered orally to 6 healthy males. Blood and urine samples for uric acid and oxypurine were collected before and up to 6 hours after losartan administration. The same examinations were performed later using enalapril (5 mg).

Results: Losartan decreased the serum uric acid concentration (from 5.9 +/- 0.9 to 5.2 +/- 1.0 mg/dl) and increased its fractional clearance, which reached a maximum after 2 hours, while enalapril did not. Losartan also induced an increase in the plasma concentration of hypoxanthine, peaking in the fourth hour, and a decrease in its urinary clearance, while the plasma xanthine concentration and its urinary clearance were unchanged. The extent of uric acid excretion was much greater than that of the oxypurines.

Conclusions: Losartan, which has a high affinity for the urate/anion exchanger, has a transient uricosuric effect. Our data indicate that losartan induces a significant decrease in the urinary excretion of hypoxanthine without changes in xanthine.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Angiotensin Receptor Antagonists*
  • Antihypertensive Agents / pharmacology*
  • Enalapril / pharmacology
  • Humans
  • Hypoxanthine / urine
  • Losartan / pharmacology*
  • Male
  • Oxypurinol / urine*
  • Uric Acid / blood*
  • Xanthine / urine


  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Xanthine
  • Uric Acid
  • Hypoxanthine
  • Enalapril
  • Oxypurinol
  • Losartan